Evidence map›Paper›PMID 28893983›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Mechanisms for restraining cAMP-dependent protein kinase revealed by subunit quantitation and cross-linking approaches.

Ryan Walker-Gray, Florian Stengel, Matthew G Gold

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. cAMP signaling: a remarkably regional affair.Trends in biochemical sciences · 2024
    Review
  18. The focal adhesion protein talin is a mechanically gated A-kinase anchoring protein.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ryan Walker-GrayDepartment of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.
Florian StengelDepartment of Biology, University of Konstanz, 78457 Konstanz, Germany.
Matthew G GoldDepartment of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom; m.gold@ucl.ac.uk.
University College London · GBUniversity of Konstanz · DE

Funding

Biotechnology and Biological Sciences Research Council BB/N015274/1Wellcome TrustWellcome Trust 104194/Z/14/Z
6 · The paper itself

Abstract

Protein phosphorylation by cyclic AMP-dependent protein kinase (PKA) underlies key cellular processes, including sympathetic stimulation of heart cells, and potentiation of synaptic strength in neurons. Unrestrained PKA activity is pathological, and an enduring challenge is to understand how the activity of PKA catalytic subunits is directed in cells. We developed a light-activated cross-linking approach to monitor PKA subunit interactions with temporal precision in living cells. This enabled us to refute the recently proposed theory that PKA catalytic subunits remain tethered to regulatory subunits during cAMP elevation. Instead, we have identified other features of PKA signaling for reducing catalytic subunit diffusion and increasing recapture rate. Comprehensive quantitative immunoblotting of protein extracts from human embryonic kidney cells and rat organs reveals that regulatory subunits are always in large molar excess of catalytic subunits (average ∼17-fold). In the majority of organs tested, type II regulatory (RII) subunits were found to be the predominant PKA subunit. We also examined the architecture of PKA complexes containing RII subunits using cross-linking coupled to mass spectrometry. Quantitative comparison of cross-linking within a complex of RIIβ and Cβ, with or without the prototypical anchoring protein AKAP18α, revealed that the dimerization and docking domain of RIIβ is between its second cAMP binding domains. This architecture is compatible with anchored RII subunits directing the myristylated N terminus of catalytic subunits toward the membrane for release and recapture within the plane of the membrane.

Indexed as

A Kinase Anchor ProteinsAnimalsCatalytic DomainCell LineCyclic AMPCyclic AMP-Dependent Protein Kinase RIIbeta SubunitHEK293 CellsHumansMaleMass SpectrometryMembrane ProteinsMyocardiumMyocytes, CardiacPhosphorylationProtein BindingProtein Structure, SecondaryAKAP7 protein, humanA Kinase Anchor ProteinsCyclic AMPCyclic AMP-Dependent Protein Kinase RIIbeta SubunitMembrane ProteinscAMPcross-linkingprotein kinaseprotein structureXL-MS

Identifiers

PMID28893983
PMCPMC5625894
OpenAlexW2754155872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.